IDE researcher René van Egmond part of joint proton therapy research

News - 11 December 2019 - Communication

HollandPTC, the proton therapy centre in Delft, has announced that five new research projects have been awarded funding from the HollandPTC R&D consortium. Among these projects is the Human-centric AI for contouring in head-and-neck cancer project, of which Industrial Design Engineering researcher René van Egmond will take part.

The main aim is to initiate a research program targeted at the development, implementation, and evaluation of human-centric AI and man-machine interaction for highly efficient re-contouring and quality assurance (QA) in head-and-neck cancer, as one of the enabling technologies and unmet needs for image-guided online-adaptive proton therapy (IGOAPT). 

HollandPTC is an independent outpatient centre for proton therapy, scientific research and education in Delft. It was founded by Erasmus Medical Centre, Leiden University Medical Centre and TU Delft. Together with national and international proton centres, universities, hospitals, patient assocatiions and healthcare insurers, HollandPTC researches for which forms of cancer proton therapy is best suited and most cost effective. Another aim is to improve proton therapy care.